Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial
Launched by HOSPITAL AUTHORITY, HONG KONG · Nov 23, 2007
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or above
- • Ethnic Chinese male or female
- • Smokes at least 2 cigarettes per day
- • Have no intention to quit in the near future
- • Intends to reduce smoking in the next 7 days
- • Has no contraindication to NRT
- Exclusion Criteria:
- • Subjects who are psychologically or physically unable to communicate
- • Children and teenagers (age below 18)
- • Pregnant or intention to become pregnant within the next 6 months
- • Those on regular psychotropic medications and in the presence of any serious health problems that may make them unsuitable for using NRT, such as recent stroke, palpitation, or other life threatening conditions
About Hospital Authority, Hong Kong
The Hospital Authority of Hong Kong is a statutory body responsible for managing the public healthcare system in Hong Kong. Established in 1990, it oversees a network of public hospitals and clinics, delivering comprehensive medical services to the community. The authority is committed to advancing medical research and innovation, facilitating clinical trials that aim to improve patient care and health outcomes. With a focus on ethical standards and regulatory compliance, the Hospital Authority collaborates with local and international research institutions to enhance the quality of healthcare through evidence-based practices and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Hong Kong, , China
Hong Kong, , China
Patients applied
Trial Officials
TH Lam, Prof
Principal Investigator
Department of Community Medicine, Faculty of Medicine, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials